Home
Storia in 1 fonti
Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more
The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
Raccontata da
statnews.com
Timeline cronologica
- ·
Pharmalittle: We're reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology
- ·
Nonprofit buys experimental cancer drug to maintain patient access
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
- ·
Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more
The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta